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E-mail address: ttj@bjmu.edu.cn (T. Tong).ING1protein is a tumor suppressorwhich plays signiﬁcant roles inmultiple cellular activities. p47ING1a
and p33ING1b are major splice isoforms of ING1 and their roles in senescence need further investiga-
tions. Herewe studied the functions of ING1 isoforms in cellular senescence and gene regulation,with
focus on p16INK4a.We observe that p33ING1b protein is themajor ING1 isoformexpressed in 2BS human
diploid ﬁbroblasts. Overexpression of p33ING1b induces cellular senescence and upregulates p16INK4a
expression in 2BS ﬁbroblasts. p33ING1b upregulates p16INK4a transcription. p33ING1b and p300 bind to
the p16INK4a promoter. p300/CBP-speciﬁc inhibitor curcumin can reverse the induction of p16INK4a
by p33ING1b. These results help to better understand the function of ING1.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
ING1 (inhibitor of growth1) protein functions as a type II tumor
suppressor which plays a signiﬁcant role in multiple cellular activi-
ties such as growth regulation, DNA repair, apoptosis and senes-
cence [1]. ING1 gene was cloned in 1996 [2], and several years
later, its isoforms p47ING1a, p33ING1b and p24ING1c were character-
ized [3]. Current evidence suggests many functions of ING1 rely on
p53 [4,5]. However, some other results obtained from different cell
lines implicated that ING1 could function in a p53-independent
manner [6,7]. Given the facts that ING1 proteins are involved in
chromatin remodeling through association with HAT (histone acet-
yl-transferase) or HDAC (histone deacetylase) complexes, it was
suggested that ING1 proteinsmight regulate target gene expression
through localized chromatin modiﬁcation [8–10].
The ﬁrst analysis of ING1 in cell senescence identiﬁed ING1 pro-
tein had pro-senescence effect, but at that time it was unable to tell
which isoform of ING1 exert such effect [11]. Later, it was reported
p33ING1b overexpression induced features of cellular senescence in
human diploid ﬁbroblasts cells [12,13]. But another study showedchemical Societies. Published by E
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.that p47ING1a but not p33ING1b had the potential to promote senes-
cent cell morphology [14].
Here we tried to dissect the expression level and function of
ING1 isoforms in replicative cellular senescence. And it is well
known that p16INK4a plays important role in replicative senescence.
So we investigated whether ING1 isoforms could inﬂuence cellular
senescence with focus on p16INK4a expression. And we attempted
to dissect the molecular mechanism. Our results indicate that
p33ING1b is the major isoform of ING1 expressed in 2BS ﬁbroblasts.
p33ING1b promotes cellular senescence by upregulation of p16INK4a
expression. And p33ING1b interacts in vivo with the p16INK4a pro-
moter and requires HAT activity to increase p16INK4a expression.
These observations help to further understand the biological func-
tions of ING1 isoforms in cellular senescence.
2. Materials and methods
2.1. Cell culture and reagent
Human embryonic lung ﬁbroblast cell line (2BS cells) was
obtained from the National Institute of Biological Products (Beijing,
China) and cultured as described previously [15]. 2BS cells are con-
sidered to be young at PD30 (population doubling30) or below and
to be fully senescent at PD55 or above. Senescent cells are charac-
terized by an irreversible growth arrest.
Human embryonic kidney cell line (HEK293 cells) was cultured
in DMEM medium, containing 10% fetal bovine serum. Curcumin,lsevier B.V. All rights reserved.
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and used at indicated concentration.
2.2. Plasmids construction
Expression plasmids of p47ING1a and p33ING1b cDNA in the pCI
vector were gifts of Professor Karl Riabowol. Plasmids were
digested by EcoRI and XbaI, and cloned into pcDNA3.1 (Invitrogen)
or pLVX-IRES-ZsGreen1 (Clontech) linearized with the same
enzymes. 50-fragment of human p16INK4a promoter was digested
with XhoI and HindIII or exempliﬁed by PCR from pSIR-EGFP vector
[16], and inserted into pGL3-Basic Luciferase Report Vector linear-
ized with the same enzymes (Promega).The p16 shRNA sequence
was as previously described [17]. The template oligonucleotides
were chemical synthesized and inserted into the pMSCV-puro-
miR30 vector.
2.3. Transfection
All plasmids were puriﬁed with Qiagen Plasmid Midi Kits. Cells
were transfected with plasmids coated by lipofectamine 2000
(Invitrogen) following the manufacturer’s indications.
To over-express p33ING1b or knock down p16INK4a in 2BS cells,
recombinant viruses were produced according to manufacturer’s
indications (Clontech).
2.4. Preparation of total RNA and qPCR
RNA preparation and qPCR (quantitative polymerase chain reac-
tion) were performed according to manufacturer’s instructions
(invitrogen). The primer sequences were as follows:
p47ING1a 50-CGGGCCTAGCGCAATAAC-30 and 50-CCCTCGGGTCA
GCAAAGAT-30;
p33ING1b 50-TCCCTGCCTTTCGACTTG-30 and 50-GCTTGCTGTTG
GGCTTGT-30;
p16INK4a 50-CAACGCACCGAATAGTTACGG-30 and 50-GCGCAGTT
GGGCTCCG-30;
p53 50-AATGCCAGAGGCTGCTCCC-30 and 50-GGTGTGGAATCA
ACCCAC-30;
b-actin 50-AGCGAGCATCCCCCAAAGTT-30 and 50-GGGCAC-
GAAGGCT CATCATT-30.
2.5. Western blot
Western bolts were performed as described [15]. The antibodies
used are anti-p16INK4a (Clone 16P04; NeoMarkers), anti-p53
(sc-126; Santa Cruze), anti-ING1 (Santa Cruze; Millipore or
Abcam, the antibody from Abcam only recognizes p33ING1b),
anti-H3K9me3 (ab8898; Abcam), anti-p300 (05–257; Millipore),
anti-b-actin (Santa Cruze) and anti-tubulin (Millipore).
2.6. SA-b-gal assays
The 2BS cells were washed twice in PBS, ﬁxed in 3% formalde-
hyde, and washed again in PBS. The cells were incubated overnight
at 37 C (without CO2) with freshly prepared SA-b-gal staining
solution as described [18].
2.7. SAHF and Immunoﬂuorescence
SAHF (senescence-associated heterochromatic foci) (DAPI foci)
were detected by staining with DAPI at room temperature. Image
collection was by a confocal microscope [18].
Immunoﬂuorescence were performed as previous described.
Stained cells were examined with a confocal laser microscope(Leica). Representative photographs from three independent
experiments are shown.
2.8. Luciferase activity assay
Twenty-four or forty-eight hours after transfection, the activi-
ties of luciferase were quantiﬁed in a luminometer (Centro LB
960; Berthold Technologies) using the Dual Luciferase Reporter
Assay System (Promega). All experiments were performed in
triplicate.
2.9. Chromatin immunoprecipitation
Chromatin immunoprecipitations (ChIPs) were performed
according to manufacturer’s instructions (Upstate). Re-ChIP was
performed as previously described [18].The sequences of the prim-
ers for ChIP assays were as follows:
Primer-1 1.7 kb upstream
50-CACAGGAAAAATTAGAAC-30 50-CCGAGATCGCGCCAT-30;
Primer-2 1.0 kb upstream
50-TTCCCAAAGTGCTGGGAT-30 50-GGGGTTGTTGTGAGTTTA-30;
Primer-3 200 bp upstream
50-CCCCG ATTCA ATTTG GCAGT-30 50-CAGCG TTGGC AAGGA AG-
GAG-30;
Primer-4 End of INK4A exon 1a
50-AGAGGGTCTGCAGCGG-30 50-TCGAAGCGCTACCTGATTCC-30;
GAPDH promoter
50-TACTAGCGGTTTTACGGGCG-30 50-TCGAACAGGAGGAGCAGA-
GAGCGA-30.
2.10. Statistics
All values are expressed as means ± S.D. in the ﬁgures. Student0s
t-test was used to perform statistical analyses. Differences with
⁄P < 0.05 were considered signiﬁcant.3. Results
3.1. Expression levels of p47ING1a and p33ING1b in replicative senescence
process of 2BS cells
Reportedly, p47ING1a and p33ING1 are twomajor isoforms of ING1
inhumancells. Theyhave conservedC-terminus,while havedistinct
N-terminus with different afﬁnities for HATs and HDACs (Fig. 1A).
We tested the total protein and mRNA levels of ING1 isoforms in
2BS cells. p16INK4a expression was also detected at the same time
to indicate the senescent state of 2BS cells. The results showed that
theRNA levels of p47ING1awerehigher inmiddle-agedand senescent
2BS cells than young 2BS cells; and p33ING1b mRNA expression was
upregulated in middle-aged 2BS cells and decreased in young and
senescent cells (Fig. 1B). The total protein levels of p47ING1a were
too low to detect in 2BS cells; while p33ING1b protein levels were
consistentwith itsmRNA levels. As ING1proteinparticipates in gene
transcriptional control, we detected ING1 expression in chromatin
fractionsof 2BSﬁbroblasts. The results showed thatp33ING1b expres-
sion increased in chromatin fractions of middle-aged and senescent
2BS cells. Notably, protein andmRNA levels of p16INK4a increased in
the middle-aged and senescent 2BS cells in which chromatin frac-
tion levels of p33ING1b increased (Fig. 1C).
3.2. p33ING1b induces senescent markers and p16INK4a expression in 2BS
cells
To test whether p33ING1b plays roles in senescence progress of
2BS cells, we detected the cellular senescence markers in p33ING1b
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Fig. 1. The expression levels of p47ING1a and p33ING1b in young, middle-aged and senescent 2BS cells. (A) Schematic representation of INGI isoforms p47ING1a and p33ING1b.
PIP = PCNA-interacting protein motif; PB = partial bromodomain; NCR = novel conserved region; NLS = nuclear localization sequence; PHD = plant homeodomain; PBR,
polybasic region. (B) The mRNA expression of ING1 transcripts by qPCR analysis. (C) Total protein levels (upper panel) and chromatin levels (lower panel) of ING1 isoforms in
young (Y; PD17), middle-aged (M; PD43) and senescent (S; PD65) 2BS cells. The histones were detected by coomassie blue staining. A representative result of three separate
experiments is shown.
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expressing of p33ING1b efﬁciently induced the expression of SA-b-
gal activity, ﬂattened senescent cell morphology, and SAHF DNA
staining pattern which is indicated by co-localization with
H3K9Me3 (Fig. 2A and B).
To gain insights into the possible relationship of ING1 isoforms
with senescence-related genes, we investigated the effects of ING1
isoforms on the expressions of p16INK4a and p53 in 2BS cells. qPCR
and Western blot results showed that introduction of p33ING1b
upregulated p16INK4a mRNA and protein levels (Fig. 2C and D).
Moreover, p16INK4a promoter activity was upregulated by p33ING1b
(Fig. 2E). Reportedly, ING1 proteins regulate p53 protein by post-
transcriptional mechanisms [4,5]. Consistent with that, our results
showed that p53 protein levels were slightly upregulated by
p33ING1b, while the mRNA level of p53 did not increase (Fig. 2C
and D). These results suggested that p33ING1b may play roles in cel-
lular senescence partly through upregulation of p16 INK4a transcrip-
tion. To further verify that p33ING1b could regulate senescence via
p16INK4a, we evaluated the role of p16 in mediating the senescence
effects by p33ING1b in 2BS cells. 2BS cells infected with both
p33ING1b and p16-shRNA or with p33ING1b or p16-shRNA
alone were monitored. The results showed that cells treated
with p33ING1b alone revealed strong SA-b-gal staining and p16
increasing, whereas cells doubly treated with p33ING1b and
p16-shRNA reversed the senescence phenotypes. As expected,
p16-shRNA-infected cells displayed young phenotypes (Fig. 2F).
To conﬁrm the effects of p33ING1b on p16INK4a expression, we
overexpressed p33ING1b in HEK293 cells, and analyzed the protein
expressions, mRNA levels and promoter activities of p16INK4a.
p53 levels were also detected as controls. The results showed that
p33ING1b markedly increased p16INK4a protein level, mRNA leveland promoter activity in HEK293 cells (Fig. 2G–I). p53 mRNA
expression did not increase, which is in agreement with 2BS ﬁbro-
blasts. These results showed a well correlation of promoter activ-
ity, mRNA levels and protein levels of p16INK4a upon ectopic
expression of p33ING1b both in 2BS ﬁbroblasts and HEK293 cells;
suggesting p16INK4a expression was regulated by p33ING1b at the
transcriptional level.
3.3. p33ING1b activates and binds to p16INK4a promoter region in vivo
To investigate the mechanism of regulation of p16INK4a tran-
scription by p33ING1b, we examined the effects of p33ING1b on dele-
tion constructs of p16INK4a transcription regulatory regions in
HEK293 cells. We used the constructs from 178 bp downstream
(+178 bp) to 1765 bp upstream (1765 bp) of the transcriptional
start site of p16INK4a. The luciferase activity assays showed that
p33ING1b activated p16INK4a promoter regions, and the main regions
contributing to over-expression of p16INK4a by p33ING1b were
located in the region from +178 to 140 bp of p16INK4a transcrip-
tional start site (Fig. 3A).
Then we examined the in vivo DNA-binding activity of p33ING1b
to p16INK4a promoter. The antibody used for ChIP assay only recog-
nized p33ING1b isoform. In HEK293 cells, both RT–PCR and qPCR for
ChIP analysis showed that p33ING1b speciﬁcally bound 200 bp
upstream of the p16INK4a transcription start site (primer set 3). This
region is also the p16INK4a promoter region signiﬁcantly activatedby
p33ING1b (Fig. 3A and B). We also found that ectopic expressed
p33ING1b bound the p16INK4a promoter in HEK293 cells, which is
the same region of p16 promoter as the endogenous p33ING1b bound
(Fig. 3C, upper panel). In 2BS cells, endogenous p33ING1b speciﬁcally
bound this region of the p16INK4a promoter (primer set 3);moreover,
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Fig. 2. Overexpression of p33ING1b induce cellular senescence and p16INK4a level. (A) SA-b-gal activity (blue) and (B) SAHF formation (left panel) in vector or p33ING1b-infected
stable cells. Immunostaining of H3K9me3 in p33ING1b-infected cells (right panel). White arrows indicated co-localization of H3K9me3 at SAHF. (C) Western blots and (D) qPCR
analysis of p16INK4a and p53 expressions in vector and p33ING1b-infected stable 2BS cells. (E) Stable infected 2BS cells were transfected with control promoter or p16
promoter. Luciferase activities were measured 24 h later. Values have been equalized relative to the value obtained with control empty vector (set at 1) and are the average of
three independent determinations. ⁄P < 0.05. (F) Western blots and SA-b-gal analysis of the effects of knocking down p16INK4a on p33ING1b-induced senescence in 2BS cells. (G)
Western blots and (H) qPCR analysis of p16INK4a and p53 expressions in vector or p33ING1b-transfected HEK293 cells. (I) Vector or p33ING1b-transfected HEK293 cells were
transfected with control promoter or p16 promoter. Luciferase activities were measured as described. ⁄P < 0.05.
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cells (Fig. 3C, lower panel). Therefore these results indicate that
p33ING1b activates and speciﬁcally binds to thep16INK4a promoter re-
gion and imply again that p33ING1b plays a role in p16INK4a transcrip-
tional regulation.
3.4. p33ING1b and p300 interact with the p16INK4a promoter to regulate
its transcription
Reportedly, p33ING1b interacts with proteins associated with
HAT activity, such as p300/CBP [8]. To examine whether the effect
of p33ING1b on p16INK4a transcription was dependent on p300/CBP
HAT activity, Re-ChIP was performed using an anti-p33ING1b anti-
body in HEK293 cells, followed by reimmunoprecipitation usingan anti-p300 antibody, and then detection of PCR-ampliﬁed signal
in the p16INK4a promoter region. The results showed that both
p33ING1b and p300 associate with the regulatory region of the
p16INK4a promoter (Fig. 4A).
Curcumin has been reported to be a p300/CBP-speciﬁc cell per-
meable HAT inhibitor [19,20]. Here curcumin was used to conﬁrm
the effects of p300/CBP HAT on p33ING1b-induced p16INK4a expres-
sion. After introduction of control vector or p33ING1b, 2BS and
HEK293 cells were incubated with 1–20 lM curcumin. The results
showed that p16INK4a protein expressions were increased in
p33ING1b-overexpressed 2BS and HEK293 cells without curcumin
treatment. While following the addition of curcumin, p33ING1b
-induced increase of p16INK4a protein expressions reduced more
than vector control cells. Treatment of cells with 20 lM curcumin
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Fig. 3. p33ING1 activates and speciﬁcally binds to p16INK4a promoter region. (A) Vector and p33ING1b-transfected HEK293 cells were transfected with constructs of p16
regulatory regions from 178 bp downstream to 1765 bp upstream p16 transcription start site. Luciferase activities were measured as described. ⁄P < 0.05. (B) Schematic
diagram of the p16 gene promoter and the end of INK4a exon 1a (upper panel). ChIP analysis was performed using primers indicated by red bars in HEK293 cells. The
precipitated DNA was ampliﬁed by RT–PCR (middle panel) and qPCR (lower panel). Values are expressed relative to the controls, which were set as 1. (C) ChIP assays of
p33ING1b transfected-HEK293 cells (upper panel); and normal young (Y), middle-aged (M) and senescent (S) 2BS cells at p16 promoter using the primer set 3. The antibody
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3110 N. Li et al. / FEBS Letters 585 (2011) 3106–3112reversed completely the effects of p33ING1b on p16INK4a protein lev-
els both in2BSandHEK293cells (Fig. 4BandC). In addition, the lucif-
erase assays for p16INK4a promoter activities showed a similar
tendency (Fig. 4D). Taken together, these results indicated that
p33ING1b bound top16INK4a promoter region in vivo, andused at least
partly HAT-dependent mechanism for transcriptional induction of
p16INK4a.
4. Discussion
Although recent studies began to attract more attention to ING1
isoforms, their biological functions have not been fully elucidated
up to date [1,21]. In the present study, we have investigated the
expressions of the two major ING1 isoforms in young, middle-aged
and senescent 2BS ﬁbroblasts and detected their functions on gene
expression and cell senescence. We observed the mRNA levels of
p47INGla increased in middle-aged and senescent human diploid
2BS ﬁbroblasts, however, its protein levels are very low in 2BS
cells; suggesting some posttranscriptional mechanisms may regu-
late p47INGla protein levels in 2BS cells. p33ING1b is the major ING1
isoform expressed in 2BS ﬁbroblasts, its mRNA and total protein
expression elevated in middle-aged 2BS cells when p16INK4a levels
began increasing, but its expression declined when cells entered
senescent state. Reportedly, ING1 proteins regulate geneexpression through regulating chromatin organization
[1,8,9,13,14]. By extracting the chromatin proteins, we found that
the expression of p33ING1b increases in chromatin fractions of both
middle-aged and senescent 2BS cells, with a more markedly in-
crease in middle-aged cells (Fig. 1). A recent study also published
chromatin expression increase of p33ING1b in Ras-induced senes-
cence in IMR-90 ﬁbroblasts [13]. Furthermore, we found that the
binding between p33ING1b and p16INK4a promoter in middle-aged
and senescent 2BS cells also increased (Fig. 3C). These results indi-
cate that p33ING1b might play a role in increasing p16INK4a gene
transcription in middle-aged and senescent 2BS ﬁbroblasts.
p16INK4a is an important gene in provoking and maintaining cellu-
lar senescence, there are several proteins regulate its transcription
in senescent cells, such as Ets1, Id1, PPARc, B-MYB and Lsh [18,22–
24]. It is clear that the p16INK4a promoter is subject to multiple
levels of control, and therefore p16INK4a regulation cannot be
explained by a single isolated pathway. Here our observations
suggest that p33ING1b might be one of the important factors in
regulating p16INK4a expression in cellular senescence.
Although p47ING1a was reported to induce senescent phenotype,
it is controversial regarding p33ING1b in cellular senescence
[12–14]. As p33ING1b protein is the major isoform of ING1 ex-
pressed in 2BS cells, we examined its role in cellular senescence.
The results showed that overexpression of p33ING1b induced some
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N. Li et al. / FEBS Letters 585 (2011) 3106–3112 3111aspects of a senescent phenotype in 2BS ﬁbroblasts, suggesting the
important roles of p33ING1b in implementation of the replicative
senescent state. It appears that senescence is not triggered by a sin-
gle, linear series of events, but instead is regulated by a complex
signaling network. p53 and p16INK4a play important roles in both
tumor suppression and cellular senescence. Reportedly, ING1 pro-
teins are functionally linked to the p53 pathway via mechanisms
including control of p53 protein stability or posttranslational mod-
iﬁcations [4,5]. Consistent with that, we observed that p53 mRNA
levels did not increase upon p33ING1b overexpression. However,
we found that p33ING1b increases p16INK4a gene mRNA, promoter
activity and protein expression in both 2BS and HEK293 cells.
And knocking down p16INK4a expression rescued the senescent
effect by p33ING1b (Fig. 2). These results suggest that p33ING1b
might increase p16INK4a expression at transcriptional level in cellu-
lar senescence, and p16INK4a is required for p33ING1b-induced pre-
mature senescence.
Recent studies have shown that ING1 proteins may regulate
gene transcription by epigenetic control [13,14]. p33ING1b binds
with the transcription co-activator CBP/p300, which is associated
with gene transcription activation [8]. So we examined whether
p33ING1b regulated p16INK4a expression through this mechanism.
We demonstrated that p33ING1b binds to and activates p16INK4apromoter to increase its transcription. Furthermore, we found that
p33ING1b and p300 co-localized in the promoter region of p16INK4a.
After using p300/CBP-speciﬁc cell permeable HAT inhibitor curcu-
min [19,20], p33ING1b-mediated induction of p16INK4a was reduced
in both 2BS and HEK293 cells (Fig. 4). These results suggest that
p33ING1b might exert its transcriptional activation of p16INK4a
through HAT-dependent mechanism.
In addition to p33ING1b, we also examined the functions of over-
expression of p47ING1a in 2BS ﬁbroblasts and HEK293 cells. Unlike
p33ING1b, overexpression of p47ING1a showed discrepant effects on
p16INK4a expression in these two cell lines (data not shown). More
investigations are needed to illustrate this discrepancy. As p33ING1b
protein is the major isoform expressed in 2BS ﬁbroblasts, in this
study we focused on the function of p33ING1b in cellular senescence
and gene regulation.
In summary, we observed that p33ING1b protein is the major
ING1 isoform expressed in 2BS ﬁbroblasts. Overexpression of
p33ING1b induces some markers of senescence in 2BS cells. More-
over, we established for the ﬁrst time that p33ING1b increases
p16INK4a expression in 2BS and HEK293 cells, p33ING1b speciﬁcally
binds and activates the p16INK4a promoter and p300/CBP HAT spe-
ciﬁc inhibitor curcumin can reverse the effect of p33ING1b on
p16INK4a. As the effect and mechanism of p33ING1b protein in
3112 N. Li et al. / FEBS Letters 585 (2011) 3106–3112cellular senescence have not been fully demonstrated, our results
may help better understand the function of p33ING1b in cellular
senescence.
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